New drug shows promise for treating heart disease in diabetes patients

Short resume:

risk
80%
diabetes
70%
johnson
70%
invokana
60%

Johnson & Johnson’s type 2 diabetes drug Invokana significantly reduced the risk of serious heart problems in patients with established heart disease or at elevated risk in a pair of large studies, according to data presented at a medical meeting on
Source CNBC
Read More…

More News


Be the first to comment

Leave a Reply

Your email address will not be published.


*